newsfilter
← Latest News
Business Wire·

AN2 Therapeutics to Participate at Upcoming Investor Conferences

AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that company